GE

276.29

+0.12%↑

RTX

151.9

-1.32%↓

CAT

417.84

-1.1%↓

BA

229.49

-0.58%↓

GEV.US

605.48

+0.89%↑

GE

276.29

+0.12%↑

RTX

151.9

-1.32%↓

CAT

417.84

-1.1%↓

BA

229.49

-0.58%↓

GEV.US

605.48

+0.89%↑

GE

276.29

+0.12%↑

RTX

151.9

-1.32%↓

CAT

417.84

-1.1%↓

BA

229.49

-0.58%↓

GEV.US

605.48

+0.89%↑

GE

276.29

+0.12%↑

RTX

151.9

-1.32%↓

CAT

417.84

-1.1%↓

BA

229.49

-0.58%↓

GEV.US

605.48

+0.89%↑

GE

276.29

+0.12%↑

RTX

151.9

-1.32%↓

CAT

417.84

-1.1%↓

BA

229.49

-0.58%↓

GEV.US

605.48

+0.89%↑

Search

India Globalization Capital Inc

Fechado

0.4 -2.44

Visão Geral

Variação de preço das ações

24h

Atual

Mín

0.4

Máximo

0.42

Indicadores-chave

By Trading Economics

Rendimento

-402K

-1.6M

Vendas

-2K

328K

EPS

-0.015

Margem de lucro

-487.5

Funcionários

70

EBITDA

-506K

-1.8M

Dividendos

By Dow Jones

Próximos Ganhos

10 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

11M

40M

Abertura anterior

2.84

Fecho anterior

0.4

India Globalization Capital Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

9 de set. de 2025, 23:37 UTC

Ações em Alta

Stocks to Watch: Oracle, Wearable Devices, GameStop

9 de set. de 2025, 20:41 UTC

Ganhos

Oracle's Backlog Surges With Major Customer Deals in 1Q

9 de set. de 2025, 20:30 UTC

Ganhos

GameStop 2Q Sales, Profit Rise

9 de set. de 2025, 23:19 UTC

Conversa de Mercado

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

9 de set. de 2025, 21:35 UTC

Ganhos

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

9 de set. de 2025, 21:32 UTC

Ganhos

Oracle's Backlog Swells With Big Customer Deals -- Update

9 de set. de 2025, 21:02 UTC

Aquisições, Fusões, Aquisições de Empresas

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

9 de set. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

9 de set. de 2025, 20:33 UTC

Ganhos

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

9 de set. de 2025, 20:26 UTC

Ganhos

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 de set. de 2025, 20:23 UTC

Ganhos

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 de set. de 2025, 20:12 UTC

Ganhos

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

9 de set. de 2025, 20:10 UTC

Ganhos

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

9 de set. de 2025, 20:10 UTC

Ganhos

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

9 de set. de 2025, 20:09 UTC

Ganhos

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

9 de set. de 2025, 20:09 UTC

Ganhos

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

9 de set. de 2025, 20:08 UTC

Ganhos

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

9 de set. de 2025, 20:08 UTC

Ganhos

Oracle 1Q Operating Income Was $4.3 B >ORCL

9 de set. de 2025, 20:08 UTC

Ganhos

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

9 de set. de 2025, 20:08 UTC

Ganhos

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

9 de set. de 2025, 20:07 UTC

Ganhos

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

9 de set. de 2025, 20:06 UTC

Ganhos

Oracle 1Q Software Revenue $5.72B >ORCL

9 de set. de 2025, 20:06 UTC

Ganhos

Synopsys 3Q Adj EPS $3.39 >SNPS

9 de set. de 2025, 20:06 UTC

Ganhos

Oracle 1Q Cloud Revenue $7.19B >ORCL

9 de set. de 2025, 20:05 UTC

Ganhos

Oracle 1Q Rev $14.93B >ORCL

9 de set. de 2025, 20:05 UTC

Ganhos

Oracle 1Q EPS $1.01 >ORCL

9 de set. de 2025, 20:05 UTC

Ganhos

Synopsys 3Q EPS $1.50 >SNPS

9 de set. de 2025, 20:05 UTC

Ganhos

Oracle 1Q Services Revenue $1.35B >ORCL

9 de set. de 2025, 20:05 UTC

Ganhos

Oracle 1Q Adj EPS $1.47 >ORCL

9 de set. de 2025, 20:05 UTC

Ganhos

Oracle 1Q Hardware Revenue $670M >ORCL

Comparação entre Pares

Variação de preço

India Globalization Capital Inc Previsão

Consenso de Avaliação

By TipRanks

0 ratings

0

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre India Globalization Capital Inc

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
help-icon Live chat